Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Interim Management Statement

9 May 2014 07:00

RNS Number : 6551G
LMS Capital PLC
09 May 2014
 



 

 

 

 

 

 

 

 

 

 

9 May 2014

 

LMS Capital plc ("the Company")

Interim Management Statement

 

The Board of LMS Capital is pleased to present the Company's Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement relates to the period from 1 January 2014 to 8 May 2014.

 

LMS Capital is an investment company which, following a general meeting on 30 November 2011, is undertaking a realisation strategy with the aim of achieving a balance between an efficient return of cash to shareholders and optimising the value of the Company's investments. Its investment portfolio consists of small to medium sized companies across a range of sectors.

 

The Company had cash of £18.9 million at 31 March 2014. On that date we completed the sale of our largest investment, Updata Infrastructure (UK) Limited, and the proceeds were received early in April. Net proceeds of this transaction (after transaction expenses and carried interest) were £27.2 million. Other proceeds from realisations in the first quarter were fund distributions of £4.1 million. In the same period calls from our outstanding fund commitments were £0.6 million, leaving uncalled commitments to funds at 31 March 2014 of £7.9 million.

 

The Company's unaudited net asset value per share at 31 March 2014 was 94 pence, an increase of 6 pence from 88 pence as at 31 December 2013. The principal factors in this increase were:

· the realised net gain equivalent to 4p per share on the sale of our interest in Updata, and

· unrealised gains on our quoted investments, in particular Weatherford International and ChyronHego Corporation, amounting to 2p per share. Around two thirds of this increase arose on our shareholding in Weatherford International.

 

 Since 31 March 2014, the share price of Weatherford International has improved further and, in isolation, this improvement increases the Company's NAV per share by 2p compared to 31 March 2014. However, the recent strengthening of £ sterling against the US dollar has resulted in unrealised exchange losses and therefore at the date of this report the increase in NAV per share since the end of the first quarter is around 1p per share.

 

Since the end of the first quarter, the Company has sold 10% of its holding in Weatherford International for net proceeds of approximately £2.6 million.

 

The Directors have previously stated their aim to announce a further distribution to shareholders later this year and today we have made a separate announcement explaining that we are sending a circular to shareholders setting out details of a proposed tender offer in relation to a return of up to a further £40 million to shareholders.

If taken up in full, this would bring to £115 million the total capital returned to shareholders since the Company's realisation strategy was approved by shareholders on 30 November 2011. This would equate to around 48% of the net asset value at the end of 2011 and approximately 74% of the Company's market capitalisation at the time of the November 2011 General Meeting.

Investments

 

The carrying value of the investment portfolio at 31 March 2014 is based on the valuation of the Company's investments as at 31 December 2013 with adjustments for transactions in the three months ended 31 March 2014 including price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds and purchases and sales of quoted and unquoted securities. The next full valuation of the portfolio will be for our half year results as at 30 June 2014.

 

The Company's investment portfolio at 31 March 2014 (and 31 December 2013) was as follows:

 

31 March 2014

31 December 2013

£'000

£'000

US

Quoted

25,794

22,630

Unquoted

28,988

29,885

Funds

37,350

39,990

US total

92,132

92,505

UK

Quoted

1,484

1,406

Unquoted

15,154

34,654

Funds

28,077

29,156

UK total

44,715

65,216

Total

136,847

157,721

 

Details of our ten largest investments by valuation at 31 March 2014, representing approximately 69% of the total portfolio, are set out in the appendix to this statement.

 

This statement is a general description of the financial position and performance of the Company for the period from 1 January 2014 to 8 May 2014. It does not contain any profit forecast or forward looking information. Future NAV and share price performance are likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

 

 

For further information please contact:

 

LMS Capital plc 020 7935 3555

Nick Friedlos, Executive Director

Tony Sweet, Chief Financial Officer

 

J.P. Morgan Cazenove 020 7742 4000

Michael Wentworth-Stanley

 

MHP Communications 020 3128 8100

Tim McCall

Katie Hunt

 

About LMS Capital

LMS Capital is an investment company which, following a general meeting on 30 November 2011, is undertaking a realisation strategy with the aim of achieving a balance between an efficient return of cash to shareholders and optimising the value of the Company's investments. Its investment portfolio consists of small to medium sized companies across a range of sectors.

www.lmscapital.com

 

 

 

LMS Capital plc Appendix

 

Interim management statement - 9 May 2014

 

The Company's principal investments by valuation at 31 March 2014 were as follows:

 

Name

Geography

Type

Sector

Date of initial investment

Book value

£'m

Weatherford International

 

US

Quoted

Energy

1984

21.3

Brockton Capital

 

UK

Funds

Property

2006

15.2

Medhost Inc (formerly HealthTech)

US

Unquoted

Technology

2007

12.5

Yes To, Inc*

US

Unquoted

Consumer

2008

10.2

 

Nationwide Energy Partners

 

US

Unquoted

Energy

2010

9.8

BV Investment Partners

 

US

Funds

Buyouts

1996

5.6

Entuity

 

UK

Unquoted

Technology

2000

5.5

Penguin Computing*

US

Unquoted

Linux server systems

2004

5.5

ICU Eyewear*

US

Unquoted

Consumer

2010

4.9

ChyronHego Corporation

US

Quoted

Technology

1995

4.1

 

*San Francisco Equity Partners manages these investments.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSIFMAFLSEDI
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.